Breaking Down NovoCure: 4 Analysts Share Their Views
Breaking Down NovoCure: 4 Analysts Share Their Views
解析NovoCure：4位分析師分享他們的觀點
4 analysts have expressed a variety of opinions on NovoCure (NASDAQ:NVCR) over the past quarter, offering a diverse set of opinions from bullish to bearish.
過去一個季度，有4位分析師對NovoCure (納斯達克股票代碼：NVCR) 發表了不同的意見，從看好到看淡的看法不一。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.0, a high estimate of $28.00, and a low estimate of $20.00. This current average reflects an increase of 7.58% from the previous average price target of $21.38.
分析師通過評估12個月的目標價格提供更深入的見解，揭示出平均目標價格爲23美元，最高估價爲28美元，最低估價爲20美元。這個當前的平均值反映了相對於之前的平均價格目標21.38美元增長了7.58%。
Investigating Analyst Ratings...
分析師...
登入免費觀看全文
登入/註冊